Dr. Macym T. Rizvi, MD

Dr. Rizvi practices at Texas Health Dallas in Dallas, Texas, part of Texas Health Resources.

Dr. Rizvi's NPI, 1962812461, was assigned on May 6, 2014. Dr. Rizvi graduated from Texas Tech University Health Sciences Center School of Medicine in 2014. Dr. Rizvi holds Texas license S1902.

Dr. Rizvi's primary practice is Texas Health Dallas, at 8200 Walnut Hill Lane, Dallas, TX 75231 in Dallas County. The practice phone is (214) 345-6789.

Dr. Rizvi's primary practice is Texas Health Dallas in Dallas, Texas, part of Texas Health Resources. Dr. Rizvi is also affiliated with Medical City Dallas Hospital. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Rizvi to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rizvi is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rizvi's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease and mobility impairment among the conditions Dr. Rizvi treats.

CMS data shows 960 Medicare services from Dr. Rizvi across 9 procedure codes in 2024, for 490 Medicare patients. Medicare paid $101,438 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 490 Medicare patients who saw Dr. Rizvi in 2024. The largest group is 75 to 84, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 64, with 55% women.

In 2019, Dr. Rizvi wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $429 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Rizvi for performance year 2024, reported as part of a group. Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Rizvi, published from 2017 to 2022. The most frequent topics are Electroencephalography, Periodicity and Seizures. Dr. Rizvi has published most often in J Clin Neurophysiol. Dr. Rizvi's most frequent co-authors are Ayham Alkhachroum, MD, Alok Sachdeva, MD and Jennifer Leigh Waldron, DO.

CMS Open Payments shows 30 general payments to Dr. Rizvi from 17 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Eisai Inc. paid the most, $185.

Dr. Rizvi graduated from Texas Tech University Health Sciences Center School of Medicine in 2014.

Dr. Rizvi is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.